Clinical trials
Glaucoma clinical trials
Below are recruiting glaucoma clinical trials, each written for real people, not researchers. We’re tracking 208 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07409077Recruiting
Biofeedback training for glaucoma patients
This study tests if biofeedback training—a technique that helps you learn to use your remaining vision better—can improve vision in people with glaucoma. It focuses on those with vision loss near the center of their sight.
Toronto, OntarioAges Any age - NCT07447011Recruiting
Glaucoma treatment response with sleep apnea lifestyle changes
This trial tests whether lifestyle changes can help open-angle glaucoma in people who also have obstructive sleep apnea and are obese. It may offer a non-drug way to manage both conditions.
Giza, DokkiAges 30–50 - NCT07454447Recruiting
Eye exam after new glaucoma surgery
This trial uses a special ultrasound to look at the eye after a certain type of glaucoma surgery. It helps doctors see how well the surgery is working for people with open-angle glaucoma.
Minya, Minya GovernorateAges Any age - NCT07462000Recruiting
Eye fluid and tissue analysis in glaucoma and cataract
This study collects eye fluid and tissue samples during planned cataract or combined cataract-glaucoma surgery to analyze differences between people with and without glaucoma. It may help researchers understand eye disease better.
WarsawAges 18 years+ - NCT07517302Recruiting
Dual Blade Surgery for Angle-Closure Glaucoma With Cataracts
This trial tests a new surgical technique called Kahook Dual Blade goniotomy combined with cataract removal in patients with chronic angle-closure glaucoma—a condition where fluid pressure builds up in the eye because drainage channels are blocked. The goal is to lower eye pressure and help preserve vision.
BeijingAges 40 years+ - NCT07523139Recruiting
Eye Structure Study in Angle-Closure Glaucoma
This research study uses ultrasound imaging to examine the internal structures of the eye in people with angle-closure glaucoma (a type of increased eye pressure) and compares them to healthy eyes. Understanding these structures may help doctors better diagnose and treat this eye condition.
BeijingAges 30–79 - NCT07588152RecruitingPhase 4
How Netarsudil Eye Drops Affect the Eye's Drain System
This study uses special imaging to see how the eye-pressure-lowering medication netarsudil (Rhopressa) works on the part of your eye that drains fluid. Researchers want to understand whether it helps restore normal drainage in people with high eye pressure or glaucoma.
Bloomington, IndianaAges 18 years+ - NCT07592988Recruiting
Tear Markers After Laser Glaucoma Treatment
This study looks at tiny proteins in your tears after a specific laser treatment for glaucoma (a disease that damages the nerve in your eye). Researchers want to understand how these tear markers change and whether they might help predict how well the treatment works.
AlmatyAges 18 years+ - NCT07599241Recruiting
Exercise Program for Older Women With Thyroid, Eye, and Liver Conditions
This study tests whether a physical activity program can help older women manage three common conditions together: an underactive thyroid, high eye pressure (glaucoma), and fatty liver disease. Researchers want to see if exercise improves symptoms and overall health when addressing multiple conditions at once.
Dokki, Giza GovernorateAges 65–75 - NCT07662759RecruitingPhase 3
Study of TFC-003 for open-angle glaucoma or high eye pressure
This trial tests a new eye drop combination (TFC-003) to lower eye pressure in people with primary open-angle glaucoma or ocular hypertension. It compares the new drug to existing treatments to see if it works better or is safer.
SeongnamAges 19 years+ - NCT07327242Enrolling by invitation
AI tool to improve eye test accuracy in glaucoma patients
This trial tests if a large language model tool can help patients perform more reliable visual field tests. It may improve detection of glaucoma progression.
Palo Alto, CaliforniaAges 18 years+ - NCT07224542Enrolling by invitation
Smart contact lenses to monitor glaucoma
This study tests a smart contact lens that may help monitor glaucoma by measuring eye pressure. It is looking for people with glaucoma (who already use eye-drop medicine) and healthy adults without glaucoma to see if the lens works well over time.
Bloomington, IndianaAges 22 years+ - NCT07003685Enrolling by invitation
Glaucoma drainage device for hard-to-treat glaucoma
This study tests a posterior chamber drainage device for people with glaucoma that is not controlled by eye drops, especially those who have already had cataract surgery. It aims to help lower eye pressure safely and prevent further vision loss.
Ho Chi Minh City, Ho Chi MinhAges 18 years+ - NCT06827535Enrolling by invitation
Long-term study of eye changes in glaucoma and high eye pressure
This study tracks changes in blood flow, structure, and vision over time in people with glaucoma or high eye pressure. It aims to understand how these conditions progress, which could help improve future treatment.
Milan, ItalyAges 18 years+ - NCT06731582Enrolling by invitationPhase 3
Nicotinamide supplement study for glaucoma patients
This trial tests whether a vitamin B3 supplement called nicotinamide can help slow down vision loss in people with glaucoma. It is for those with moderate disease who are already on treatment.
Singapore, Central SingaporeAges 21 years+ - NCT05557721Enrolling by invitation
Micropulse laser for open-angle or pseudoexfoliation glaucoma
This study tests a specific eye laser treatment (micropulse) for people with open-angle or pseudoexfoliation glaucoma. It may help lower eye pressure, and the study also checks whether patients can follow the treatment plan and follow-up visits.
Skövde, Västra Götaland CountyAges 18 years+ - NCT05432245Enrolling by invitation
Glaucoma implant placed during cataract surgery
This trial looks at whether placing a small glaucoma implant at the same time as cataract surgery can better control eye pressure in people with primary open-angle glaucoma. It may help reduce the need for medicines or improve control, depending on how your eyes respond.
Panama CityAges 40 years+ - NCT05159960Enrolling by invitation
Repeat laser eye treatment study for eligible prior participants
This study is for people who already joined an earlier selective laser eye treatment trial and were able to be followed without needing stronger additional treatments. It looks at the best plan for repeating the laser treatment when appropriate.
Skövde, Västra Götaland CountyAges 18 years+ - NCT06976034Recruiting
High-resolution eye camera study for eye conditions
This study uses a new type of eye camera to take very detailed pictures of the front of the eye (cornea, lens, and nearby areas). It is for people with certain eye conditions or for healthy volunteers.
ParisAges 18–80 - NCT05180994RecruitingPhase 1/Phase 2
Infliximab eye drops after first corneal transplant
This trial tests infliximab—given as eye drops—after a first corneal transplant to see if it can improve healing and eye outcomes. It may help people at risk of inflammation after surgery, but it also requires careful screening for infection and medication safety.
Montreal, QuebecAges 18–80 - NCT05136950Recruiting
Tracking side effects after secondary lens surgery for cataracts
This study follows children who had congenital cataract surgery to see how often glaucoma-related side effects happen after getting a secondary intraocular lens. It may help doctors better prevent and catch eye pressure problems after these surgeries.
GuangzhouAges 1.5 years–14 years - NCT06077253Recruiting
Preventing angle closure glaucoma in Danish patients
This trial tests a laser treatment to prevent a type of glaucoma called angle closure. It is for people who have a narrow drainage angle in the eye but do not yet have glaucoma or other serious eye conditions.
AalborgAges 40–80 - NCT06139523Recruiting
Improving eye imaging in adults and children
This study aims to improve how we take pictures of the back of the eye (called OCT imaging) in both healthy adults and children. It will help doctors get better images to diagnose and manage eye conditions.
Durham, North CarolinaAges Any age - NCT03648814Recruiting
Bevacizumab eye injections for neovascular glaucoma
This study compares two ways of giving the medicine bevacizumab in the eye: into the front part (intracameral) versus deeper inside (intravitreal). It aims to see which approach better controls neovascular glaucoma and helps vision, especially when surgery (trabeculectomy) is needed.
Hat Yai, Changwat SongkhlaAges 18 years+
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for glaucoma?
- Yes. Clin2 currently lists 208 recruiting glaucoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a glaucoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a glaucoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.